PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients-Reference-Cited by-同舟云学术

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients

Published:2016-11-14 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kim Hye Ryun,Ha Sang-Jun,Hong Min Hee,Heo Su Jin,Koh Yoon Woo,Choi Eun Chang,Kim Eun Kyung,Pyo Kyoung Ho,Jung Inkyung,Seo Daekwan,Choi Jaewoo,Cho Byoung Chul,Yoon Sun Och

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep36956.pdf

Reference41 articles.

1. Straub, M. et al. CD274/PD-L1 gene amplification and PD-L1 protein expression are common events in squamous cell carcinoma of the oral cavity. Oncotarget, doi:10.18632/oncotarget.7593. 102024–112034 (2016).

2. Herbst, R. S. et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515, 563–567 (2014).

3. Swanson, M. S. & Sinha, U. K. Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer-review of current data. Oral Oncol. 51, 12–15 (2015).

4. Kim, J. W. & Eder, J. P. Prospects for targeting PD-1 and PD-L1 in various tumor types. Oncology 28 Suppl 3, 15–28 (2014).

5. Fury, M., Ou, S. I., Balmanoukian, A. & Hansen, A. Clinical activity and safety of MEDI4736, an anti PD-L1 antibody, in patients with head and neck cancer [abstract 988PD]. Ann Oncol 25, iv340–iv356 (2014).

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tertiary lymphoid structure-related immune infiltrates in NSCLC tumor lesions correlate with low tumor-reactivity of TIL products;OncoImmunology;2024-08-22

2. The expression of immune checkpoint proteins PD‐L1 and TIM3 in mouse and human head and neck squamous cell carcinoma;European Journal of Oral Sciences;2024-08

3. Guanylate binding protein 5 is an immune‐related biomarker of oral squamous cell carcinoma: A retrospective prognostic study with bioinformatic analysis;Cancer Medicine;2024-07

4. Crosstalk between CAFs and tumour cells in head and neck cancer;Cell Death Discovery;2024-06-26

5. Programmed death-ligand 1 expression in carcinoma of unknown primary;BMC Cancer;2024-06-06